不圆 发自 凹非寺 量子位 | 公众号 QbitAI ChatGPT的对话流畅性、Gemini的多模态能力、DeepSeek的长上下文分析…… 能不能让它们强强联合，共同解决问题呢？ 那个由Transformer作者之一Llion Jones创立的明星AI公司 Sakana AI ，提出了新方法 AB-MCTS ，核心思想是： 最伟大的成就往往源于不同思想的协作，我们相信这一原则同样适用于人工智能。 AB-MCTS，全称为自适应分支蒙特卡洛树搜索（Adaptive Branching Monte Carlo Tree Search），是一种 使多个人工智能模型同时处理 问题 的算法。模型之间交换并完善建议，协同工作，就像人类团队一样。 在具有挑战性的ARC-AGI-2基准测试中，多LLM AB-MCTS解决的问题比单独工作的任何单个模型（Single-LLM AB-MCTS）都多。 有几种情况下，只有不同模型的组合才能得出正确答案。 Sakana AI已将该算法以 TreeQuest 的名称开源，链接可见文末。 两种搜索策略 AB-MCTS结合了两种不同的搜索策略：它可以完善现有解决方案（深度搜索），也可以尝 ...

Adaptive computing enables users to build the exact processing pipeline for their needs. With CPUs and GPUs, the compute pipeline is fixed. You can program with the instruction set, but cannot change how the instructions are implemented.With adaptive computing, you can build custom instruction sets and then control how each instruction is pipelined, potentially saving memory access and optimally balancing throughput and latency. Adaptive computing hardware may be optimized for specific applications and then ...

We often hear about AI innovation, but rarely what's possible to build with the technology in a business setting. So today, we're going to talk with the CEO and founder of a company called Snowfire AI that's built what he calls a brain for your business. And I'm joined today in studio by that man, Greg Anugoo is here. Greg, great to see you. Welcome to the channel, Alex. Thank you for having me today. Thank you for being here. And I should note that this video is being sponsored by Snowfire AI. So appreciat ...

SEATTLE, July 01, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, and Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point-of-care solutions in oncology, today announced the integration of Adaptive’s clonoSEQ® test for measurable residual disease (MRD) assessment in lymphoid ma ...

Core Insights - Q32 Bio Inc. has appointed Dr. Adrien Sipos as Interim Chief Medical Officer, succeeding Dr. Jason Campagna, who is leaving the company [1][2] - Dr. Sipos brings over 25 years of experience in clinical development and medical affairs, particularly in Immunology and Inflammation [1][2] - The company is advancing its Phase 2a clinical trial for bempikibart, a treatment for alopecia areata, with topline results expected in the first half of next year [2][3] Company Overview - Q32 Bio is a clinical stage biotechnology company focused on developing therapies for alopecia areata and other autoimmune and inflammatory diseases [3] - Approximately 700,000 individuals in the U.S. are affected by alopecia areata, which significantly impacts their lives and has limited treatment options [3] - Bempikibart (ADX-914) is a fully human anti-IL-7Rα antibody that aims to re-regulate adaptive immune function and is currently in a Phase 2 program [3] Leadership Background - Dr. Sipos previously served as President and Chief Medical Officer at PRAXICO Inc., advising biopharmaceutical companies on clinical development [2] - She has held significant roles at Biogen, Sanofi Genzyme, and Eli Lilly, focusing on immunology and clinical development [2] - Dr. Sipos holds a Ph.D. in Clinical Immunology and an M.D. specializing in clinical immunology and endocrine care [2]

Apple previewed iOS 26 at WWDC and probably the biggest change was the new liquid glass design. And while folks have a lot of opinions about how attractive it is or how easy it is to read, there are a bunch of other iOS 26 features that deserve your attention. This is all things mobile and let's get into iOS 26. So iOS 26 is the follow-up to iOS 18 and will be released this fall.Now, Apple will release a public beta version of iOS 26 in July, but right now, the developer beta for iOS 26 is out, and I've bee ...

REHOVOT, Israel, June 23, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, today announced the presentation of new preclinical data on its novel CAPTN-3 tri-specific antibody platform in a poster presentation at the 2025 Annual Congress of the European Association for Cancer Research (EACR 2025), that was held in Lisbon, Portugal fr ...

As we all gathered here today, we probably realize career professionals are going through perhaps their most uncertain times ever in their lives. People with 20 plus years of experience are wondering, will they keep their job in the next 1 month or no? Fresh graduates are applying into roles that never existed when they started their graduation. And almost every professional across the world is wondering, am I relevant? Have I done enough? Will I keep my job? Well, it may sometimes feel like you're the cons ...

AI 搜索 Agent 产品 Genspark 近期被 Anthropic 官方点名了。 「 Less structure, more intelligence .」是 AI 搜索 Agent 产品 Genspark 一直以来坚持的基本原则。 Genspark 团队认为， 过度结构化的工作流程会限制创造力和深度，赋予专业 Agent 更多自主权，自由 选择并灵活运用多种工具来处理问题，反而能释放出更强的能力。 而 Genspark 灵活、能够动态协调的专业 Agent 的背后，是基于 Anthropic 的 Claude 模型的能力。 Anthropic 官网近期发布了一篇关于 Genspark 的案例研究文章，详细介绍了 Genspark 如何突破传统固定 搜索工作流程的局限、选择 Claude 实现自适应智能以及 Claude 如何驱动其动态协调的「Super Agent」 等内容。 以下为文章全文内容。 01 使用 Claude 取得的关键成果 02 最新、最值得关注的 AI 新品资讯； 不定期赠送热门新品的邀请码、会员码； 最精准的AI产品曝光渠道 超级 Agents（Super Agent）推出 4 ...

AI 搜索 Agent 产品 Genspark 近期被 Anthropic 官方点名了。 邀请从业者、开发人员和创业者，飞书扫码加群： 进群后，你有机会得到： 01 使用 Claude 取得的关键成果 「 Less structure, more intelligence .」是 AI 搜索 Agent 产品 Genspark 一直以来坚持的基本原则。 Genspark 团队认为， 过度结构化的工作流程会限制创造力和深度，赋予专业 Agent 更多自主权，自由 选择并灵活运用多种工具来处理问题，反而能释放出更强的能力。 而 Genspark 灵活、能够动态协调的专业 Agent 的背后，是基于 Anthropic 的 Claude 模型的能力。 Anthropic 官网近期发布了一篇关于 Genspark 的案例研究文章，详细介绍了 Genspark 如何突破传统固定 搜索工作流程的局限、选择 Claude 实现自适应智能以及 Claude 如何驱动其动态协调的「Super Agent」 等内容。 以下为文章全文内容。 超 6000 人的「AI 产品市集」社群！不错过每一款有价值的 AI 应用。 02 最新、 ...